CRL Annual Accounts Receivable
$578.08 M
+$18.67 M+3.34%
30 December 2023
Summary:
As of January 21, 2025, CRL annual accounts receivable is $578.08 million, with the most recent change of +$18.67 million (+3.34%) on December 30, 2023. During the last 3 years, it has risen by +$89.03 million (+18.21%). CRL annual accounts receivable is now at all-time high.CRL Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly Accounts Receivable
$557.76 M
-$10.52 M-1.85%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly accounts receivable is $557.76 million, with the most recent change of -$10.52 million (-1.85%) on September 28, 2024. Over the past year, it has dropped by -$20.32 million (-3.51%). CRL quarterly accounts receivable is now -5.78% below its all-time high of $591.98 million, reached on September 30, 2023.CRL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.3% | -3.5% |
| 3 y3 years | +18.2% | -3.5% |
| 5 y5 years | +56.2% | -3.5% |
CRL Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.1% | -5.8% | +14.0% |
| 5 y | 5-year | at high | +46.1% | -5.8% | +40.9% |
| alltime | all time | at high | +1680.6% | -5.8% | +1113.9% |
Charles River Laboratories International Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $557.76 M(-1.9%) |
| June 2024 | - | $568.28 M(-3.8%) |
| Mar 2024 | - | $590.59 M(+2.2%) |
| Dec 2023 | $578.08 M(+3.3%) | $578.08 M(-2.3%) |
| Sept 2023 | - | $591.98 M(+0.2%) |
| June 2023 | - | $591.01 M(+0.6%) |
| Mar 2023 | - | $587.71 M(+5.1%) |
| Dec 2022 | $559.41 M(+14.3%) | $559.41 M(-3.7%) |
| Sept 2022 | - | $580.63 M(+2.8%) |
| June 2022 | - | $564.72 M(+7.2%) |
| Mar 2022 | - | $526.74 M(+7.6%) |
| Dec 2021 | $489.45 M(+0.1%) | $489.45 M(-0.4%) |
| Sept 2021 | - | $491.48 M(+2.3%) |
| June 2021 | - | $480.53 M(+3.6%) |
| Mar 2021 | - | $463.80 M(-5.2%) |
| Dec 2020 | $489.04 M(+23.6%) | $489.04 M(+13.7%) |
| Sept 2020 | - | $429.94 M(+6.6%) |
| June 2020 | - | $403.35 M(-2.9%) |
| Mar 2020 | - | $415.36 M(+5.0%) |
| Dec 2019 | $395.74 M(+6.9%) | $395.74 M(+0.4%) |
| Sept 2019 | - | $394.13 M(-6.6%) |
| June 2019 | - | $422.03 M(+11.9%) |
| Mar 2019 | - | $377.19 M(+1.9%) |
| Dec 2018 | $370.13 M(+10.2%) | $370.13 M(-1.6%) |
| Sept 2018 | - | $376.30 M(+1.1%) |
| June 2018 | - | $372.36 M(+8.4%) |
| Mar 2018 | - | $343.55 M(+2.3%) |
| Dec 2017 | $335.84 M(+18.3%) | $335.84 M(+4.5%) |
| Sept 2017 | - | $321.47 M(+5.0%) |
| June 2017 | - | $306.24 M(+1.7%) |
| Mar 2017 | - | $301.25 M(+6.1%) |
| Dec 2016 | $284.00 M(+23.5%) | $284.00 M(+2.1%) |
| Sept 2016 | - | $278.04 M(+2.9%) |
| June 2016 | - | $270.33 M(+13.9%) |
| Mar 2016 | - | $237.43 M(+3.2%) |
| Dec 2015 | $230.01 M(+5.0%) | $230.01 M(-4.3%) |
| Sept 2015 | - | $240.31 M(+2.9%) |
| June 2015 | - | $233.57 M(+2.5%) |
| Mar 2015 | - | $227.89 M(+4.0%) |
| Dec 2014 | $219.12 M(+15.1%) | $219.12 M(-4.5%) |
| Sept 2014 | - | $229.37 M(+0.1%) |
| June 2014 | - | $229.19 M(+12.8%) |
| Mar 2014 | - | $203.11 M(+6.7%) |
| Dec 2013 | $190.42 M(+9.0%) | $190.42 M(-0.4%) |
| Sept 2013 | - | $191.18 M(-0.3%) |
| June 2013 | - | $191.75 M(+4.6%) |
| Mar 2013 | - | $183.36 M(+4.9%) |
| Dec 2012 | $174.77 M | $174.77 M(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $184.32 M(+3.9%) |
| June 2012 | - | $177.36 M(-13.9%) |
| Mar 2012 | - | $205.89 M(+29.2%) |
| Dec 2011 | $159.38 M(-3.9%) | $159.38 M(-7.3%) |
| Sept 2011 | - | $171.90 M(-3.6%) |
| June 2011 | - | $178.34 M(-17.2%) |
| Mar 2011 | - | $215.30 M(+29.8%) |
| Dec 2010 | $165.88 M(-12.7%) | $165.88 M(-23.5%) |
| Sept 2010 | - | $216.74 M(-0.9%) |
| June 2010 | - | $218.69 M(-0.4%) |
| Mar 2010 | - | $219.68 M(+15.6%) |
| Dec 2009 | $190.10 M(-9.6%) | $190.10 M(-10.7%) |
| Sept 2009 | - | $212.87 M(+1.4%) |
| June 2009 | - | $209.89 M(-0.6%) |
| Mar 2009 | - | $211.09 M(+0.4%) |
| Dec 2008 | $210.21 M(-1.7%) | $210.21 M(-11.4%) |
| Sept 2008 | - | $237.27 M(-1.1%) |
| June 2008 | - | $240.01 M(+0.3%) |
| Mar 2008 | - | $239.38 M(+11.9%) |
| Dec 2007 | $213.91 M(+5.6%) | $213.91 M(-7.8%) |
| Sept 2007 | - | $232.04 M(+1.5%) |
| June 2007 | - | $228.62 M(+8.8%) |
| Mar 2007 | - | $210.17 M(+3.7%) |
| Dec 2006 | $202.66 M(+18.3%) | $202.66 M(+9.4%) |
| Sept 2006 | - | $185.28 M(+4.3%) |
| June 2006 | - | $177.56 M(-11.7%) |
| Mar 2006 | - | $201.07 M(+17.4%) |
| Dec 2005 | $171.26 M(-15.1%) | $171.26 M(-18.5%) |
| Sept 2005 | - | $210.16 M(-0.1%) |
| June 2005 | - | $210.31 M(+2.6%) |
| Mar 2005 | - | $204.91 M(+1.5%) |
| Dec 2004 | $201.79 M(+81.0%) | $201.79 M(+56.9%) |
| Sept 2004 | - | $128.60 M(+2.9%) |
| June 2004 | - | $124.98 M(+4.2%) |
| Mar 2004 | - | $119.92 M(+7.5%) |
| Dec 2003 | $111.51 M(+18.3%) | $111.51 M(+5.5%) |
| Sept 2003 | - | $105.65 M(-0.8%) |
| June 2003 | - | $106.47 M(+0.6%) |
| Mar 2003 | - | $105.81 M(+12.3%) |
| Dec 2002 | $94.25 M(-4.3%) | $94.25 M(-4.5%) |
| Sept 2002 | - | $98.72 M(-1.1%) |
| June 2002 | - | $99.83 M(-5.0%) |
| Mar 2002 | - | $105.13 M(+6.8%) |
| Dec 2001 | $98.48 M(+114.3%) | $98.48 M(+0.6%) |
| Sept 2001 | - | $97.94 M(+12.2%) |
| June 2001 | - | $87.27 M(+11.5%) |
| Mar 2001 | - | $78.30 M(+70.4%) |
| Dec 2000 | $45.95 M(+41.5%) | $45.95 M |
| Dec 1998 | $32.47 M | - |
FAQ
- What is Charles River Laboratories International annual accounts receivable?
- What is the all time high annual accounts receivable for Charles River Laboratories International?
- What is Charles River Laboratories International annual accounts receivable year-on-year change?
- What is Charles River Laboratories International quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly accounts receivable year-on-year change?
What is Charles River Laboratories International annual accounts receivable?
The current annual accounts receivable of CRL is $578.08 M
What is the all time high annual accounts receivable for Charles River Laboratories International?
Charles River Laboratories International all-time high annual accounts receivable is $578.08 M
What is Charles River Laboratories International annual accounts receivable year-on-year change?
Over the past year, CRL annual accounts receivable has changed by +$18.67 M (+3.34%)
What is Charles River Laboratories International quarterly accounts receivable?
The current quarterly accounts receivable of CRL is $557.76 M
What is the all time high quarterly accounts receivable for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly accounts receivable is $591.98 M
What is Charles River Laboratories International quarterly accounts receivable year-on-year change?
Over the past year, CRL quarterly accounts receivable has changed by -$20.32 M (-3.51%)